MedTrace Logo

Nucleotide Protein -3 in Epileptic Children

NCT04219930 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2020-01-09

No results posted yet for this study

Summary

Epilepsy is one of common serious neurological malfunction, characterized by recurrent unprovoked seizures. It always accompanied with multitude of complications as cognitive, behavioral, and psychiatric disorders.

Experimental studies and clinical evidence obtained in animal models of epilepsy and human brain specimen from various drug-resistant forms of epilepsy show the activation of the innate and adaptive immunity mechanisms and the induction of the associated inflammatory processes in the epileptogenic foci.

Conditions

  • Epilepsy in Children

Interventions

DIAGNOSTIC_TEST

Expression of nucleotide protein -3

Expression of nucleotide protein -3 will be measured in serum by ELISA

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
2 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-01
Primary Completion
2020-11-01
Completion
2020-12-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04219930 on ClinicalTrials.gov